MedPath

XEOMIN

XEOMIN

Approved
DIN Number

02371081

Drug Class

Human

Market Date

Jul 4, 2012

Company
HC

MERZ PHARMACEUTICALS GMBH

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02371081
AIG Number0153613002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
M03AX01 BOTULINUM TOXIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular ,  Intraglandular
AHFS Classification12:20.20.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

INCOBOTULINUMTOXINAActive
Strength: 50 UNIT / VIAL
Monograph: INCOBOTULINUMTOXINA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.